EGFR and lung carcinoma: For example, using a mathematical cancer model and EGFR-mutant lung cancer cell lines, Chmielecki et al. showed that a high–dose pulse dosing combined with a continuous low dosing of EGFR-TKI delayed the emergence of T790M-mediated resistance compared with its emergence in cells treated with a continuous standard dosing [22].